Ajanta Pharma Ltd share price logo

Ajanta Pharma Ltd (AJANTPHARM)

₹2378.61.72%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Performance

  • Day's Low

    Day's High

    ₹2,368.1
    ₹2,425
  • 52 Week's Low

    52 Week's High

    ₹1,386.6
    ₹2,540
1 Month Return-0.1 %
3 Month Return+ 11.96 %
1 Year Return+ 61.36 %
Previous Close₹2,420.35
Open₹2,425.00
Volume49.72K
Upper Circuit-
Lower Circuit-
Market Cap₹29,950.77Cr

Analyst Rating

based on 10 analysts

BUY
80.00%
Buy
10.00%
Hold
10.00%
Sell

Based on 10 analysts offering long term price targets for Ajanta Pharma Ltd. An average target of ₹2458.8

Source: S&P Global Market Intelligence

Company Information

Ajanta Pharma is a specialty pharmaceutical company with a wide range of products spanning across 30 countries. It works across therapeutic segments including AntiBiotic AntiMalarial AntiDiabetic Cardiology Gynecology Orthopedics Pediatric Respiratory and General Health products. Founded in 1973, it is headquartered in Mumbai India and has a mission of Serving Global Health Care Needs Worldwide. In their 47 years of operations, they have grown their operations by adding 7 state-of-the-art manufacturing facilities, 2 in India approved by the United States Food and Drug Administration (USFDA). Their Research & Development Centre in Mumbai has a team of over 750 scientists working on innovative products that are supplied to various government bodies in India, the US market and WHO approved programmes in Africa. The company also has 6 subsidiaries and 1 step-down subsidiary worldwide with investments in capex growing from Rs 997 crore to Rs 1225 crore. In addition, the company also has undertaken buybacks of 769230 equity shares in March 2019 and 735000 equity shares in November 2020. 16 new products were launched in FY2022, including 4 1st to market products in the country, 3 new products were launched with 8 ANDAs being filed and receiving 2 final and 1 tentative approval with 20 more pending approval from the USFDA.

Share Price: ₹2378.60 per share as on 14 Jun, 2024 04:01 PM
Market Capitalisation: ₹29,950.77Cr as of today
Revenue: ₹1,054.08Cr as on March 2024 (Q1 24)
Net Profit: ₹202.72Cr as on March 2024 (Q1 24)
Listing date: 05 Jun, 2000
Chairperson Name: Mannalal B Agrawal
OrganisationAjanta Pharma Ltd
Headquarters
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Ajanta Pharma Ltd

  • Ajanta Pharma Announces New Buyback Programme - 24 May, 2024

    Ajanta Pharma has announced a new buyback programme of ₹351 crore, on top of a dividend paid in FY24. The current buyback offers 0.8% of the total outstanding shares at a premium price of ₹2,770. With consistent revenue growth and improved EBITDA margins, Ajanta Pharma can sustain low double-digit revenue growth in FY25.

  • Ajanta Pharma's Revenues Beat Analyst Predictions - 05 May, 2024

    Ajanta Pharma's yearly results show revenues of ₹43b, beating analyst predictions by 2.2%. EPS came in at ₹64.77, 2% above expectations. The company's ten analysts forecast a 9.8% improvement in revenue to ₹47.1b and per-share earnings are expected to swell 14% to ₹74.00. Price target rose 6.8% to ₹2,425.

  • Ajanta Pharma Q4 Results Show YoY Growth in Revenue and Profit - 04 May, 2024

    Ajanta Pharmaceuticals' Q4 results show a 19.53% YoY increase in revenue and a 65.82% YoY increase in profit. However, compared to the previous quarter, there was a decline in both revenue and profit. The consensus recommendation as of May 4th is to Buy.

  • Ajanta Pharma Reports Strong Q4 Results and Approves Share Buyback - 03 May, 2024

    Ajanta Pharma reports strong Q4 results with a surge in net profit and revenue growth. The company also approves a share buyback of up to Rs.285 crore.

  • Ajanta Pharma Reports Strong Q4 Results and Approves Share Buyback - 02 May, 2024

    Ajanta Pharma's consolidated net profit rose by 66% YoY to Rs 203 crore in the March quarter, with revenue from operations growing by 20%. The company approved a share buyback of up to Rs 285 crore, involving the purchase of 10,28,881 equity shares at a price of Rs 2,770 per share. Ajanta Pharma expects its overall FY25 revenue growth to be in the low teens.

  • Ajanta Pharma to Consider Equity Share Buy-Back Proposal - 01 May, 2024

    Ajanta Pharma will be considering a proposal for buy-back of equity shares in accordance with applicable laws.

  • Ajanta Pharma Board Considers Buyback; ROE Higher Than Industry Average - 26 Apr, 2024

    Ajanta Pharma's board will consider a fourth share buyback in four years and Q4 results on May 2, 2024. The company's ROE is higher than the industry average, with future payout ratio expected to rise. Following the buyback announcement, Ajanta Pharma stock surged 3.6% and turned positive for 2024.

Insights on Ajanta Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 13.86% to 14.76% in Mar 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 66.21% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.0% return, outperforming this stock by 46.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 100.2% return, outperforming this stock by 38.9%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 210.03 Cr → 202.72 Cr (in ₹), with an average decrease of 3.5% per quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 9.11% to 8.54% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, AJANTPHARM stock has moved down by -1.5%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 1.11K Cr → 1.08K Cr (in ₹), with an average decrease of 2.6% per quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.01% to 7.76% in Mar 2024 quarter

Ajanta Pharma Ltd Valuation

Ajanta Pharma Ltd in the last 5 years

  • Overview

  • Trends

Lowest (17.12x)

June 6, 2018

Today (36.70x)

June 14, 2024

Industry (64.98x)

June 14, 2024

Highest (40.01x)

December 29, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
Nippon India Small Cap Fund - Direct Plan - Growth PlanNippon India Small Cap Fund - Direct Plan - Growth Plan0.81%
UTI Flexi Cap Fund - Growth Option - DirectUTI Flexi Cap Fund - Growth Option - Direct1.52%
Kotak Small Cap Direct GrowthKotak Small Cap Direct Growth1.51%
Nippon India Pharma Fund - Direct Plan - Growth PlanNippon India Pharma Fund - Direct Plan - Growth Plan3.15%
HDFC Large and Mid Cap Fund Direct GrowthHDFC Large and Mid Cap Fund Direct Growth0.94%

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
66.21%
0.00
Foreign Institutions
8.54%
0.00
Mutual Funds
14.76%
0.00
Retail Investors
7.76%
0.00
Others
2.73%
0.00

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Ajanta Pharma Ltd shares.

Ajanta Pharma Ltd (AJANTPHARM) share price today is ₹2378.6

Ajanta Pharma Ltd is listed on NSE

Ajanta Pharma Ltd is listed on BSE

  • Today’s highest price of Ajanta Pharma Ltd is ₹2425.
  • Today’s lowest price of Ajanta Pharma Ltd is ₹2368.1.

PE Ratio of Ajanta Pharma Ltd is 36.7

PE ratio = Ajanta Pharma Ltd Market price per share / Ajanta Pharma Ltd Earnings per share

Today’s traded volume of Ajanta Pharma Ltd(AJANTPHARM) is 49.72K.

Today’s market capitalisation of Ajanta Pharma Ltd(AJANTPHARM) is ₹29950.77Cr.

Ajanta Pharma Ltd(AJANTPHARMPrice
52 Week High
₹2540
52 Week Low
₹1386.6

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹2378.6. It is down -6.35% from its 52 Week High price of ₹2540

Ajanta Pharma Ltd(AJANTPHARM) share price is ₹2378.6. It is up 71.54% from its 52 Week Low price of ₹1386.6

Ajanta Pharma Ltd(AJANTPHARMReturns
1 Day Returns
-41.75%
1 Month Returns
-0.1%
3 Month Returns
11.96%
1 Year Returns
61.36%